All News

In a recent study, active-duty US Army servicewomen after did not use long-active reversible contraception within 3 months after delivery.

Mary Jane Minkin, MD, FACOG, MSCP, discusses key takeaways from The Menopause Society 2023 Annual Meeting, held in Philadelphia, Pennsylvania from September 27-30.

Peter Minneci, MD, MHSc, discusses a study evaluating a new algorithm capable of accurately identifying benign lesions in female patients.

Barbara A. Dehn, NP, Vice President of Women’s Health at Peppy Health, discusses topics presented at The Menopause Society which will help her in her practice.

Nanette F. Santoro, MD, chair of OBGYN at the University of Colorado School of Medicine, discusses new research on fezolinetant as a nonhormone method for managing hot flashes at the 2023 Menopause Society Annual Meeting.

Through a randomized, multicenter, open-label, controlled study, investigators determined there were no suggestions of important differences for very preterm infant body composition when comparing an exclusive human milk diet to a diet containing cow milk products.

In a recent study, patients with early-stage cervical cancer receiving radical hysterectomy had increased survivability.

In a recent study, preexposure prophylaxis nurses effectively increased rates of preexposure prophylaxis discussions, but not prescriptions.

In a recent study, increased hair cortisol levels were effective at measuring worsened cognitive health in perimenopausal women.

In a recent study, variations in physiology during aging were found between male and female participants.

Recent data from the CDC has indicated provider recommendation increases vaccine coverage among pregnant women.

In a recent study, patients with chronic vulvar pain conditions had decreased pain-related anxiety and improved sexual functioning when experiencing vulvar pleasure.

Commons forms of osteoarthritis, as well as prevention methods, were discussed at The Menopause Society 2023 annual conference.

The most recommended and non-recommended methods of nonhormone therapy for treatment of vasomotor symptoms were discussed at The Menopause Society 2023 Annual Conference.

Advancements in technology used to measure bone health in postmenopausal women were discussed at the Menopause Society 2023 Annual Meeting.

A recent study measuring sexual functioning in women with post-traumatic stress disorder was discussed at The Menopause Society 2023 Annual Meeting.

Genevieve Neal-Perry, MD, discusses how fezolinetant is effective for treating vasomotor symptoms.

In collaboration with Contemporary Pediatrics, Contemporary OB/GYN, and Contagion, Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses the benefits of having new tools to fight RSV in infants, potential vaccine hesitancy, and RSV trends currently being observed.

A nationwide recall has been issued for ibrexafungerp products after a potential cross contamination with a non-antibacterial ß-lactam drug substance was discovered.

In a recent study highlighted at the Menopause Society 2023 Annual Meeting, a correlation was found between the number of hot flashes experienced and the risk of Alzheimer’s disease among perimenopausal and postmenopausal women.

A correlation between brown adipose tissue activity and hot flashes was discussed at the Menopause Society 2023 Annual Conference.

In a recent study, increased use of cannabis to manage menopause symptoms was observed among midlife women.

In a recent study highlighted at The Menopause Society 2023 Annual Meeting, White women with a psychiatric condition were 40% more likely to receive a hormone therapy prescription than Black women.

At The Menopause Society 2023 Annual Meeting, tips on reducing weight during menopause will be discussed.

In a recent study, transgender women had reduced sperm quality compared to cisgender men, and transgender men used contraception at similar rates to cisgender women.

Ahead of the first fall and winter virus seasons in which vaccines are available for COVID-19, influenza, and respiratory syncytial virus (RSV), the Centers for Disease Control and Prevention is recommending Pfizer’s maternal vaccine to protect newborns from severe RSV illness.

In a recent study, ages at menarche and menopause, as well as pregnancy history, impacted the risk of endometrial cancer.

In a recent study, Black patients experienced more delays in receiving endometrial cancer care than White patients.